Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Protein kinase C (PKC) C1 domain is a conserved, cysteine-rich regulatory module of approximately 50 amino acids that serves as the primary sensing site for the second messenger diacylglycerol (DAG) (Newton, A. C., 2018, Chemical Reviews). Found in conventional and novel PKC isoforms, this domain coordinates two zinc ions and possesses a hydrophobic groove that accommodates DAG or exogenous ligands such as phorbol esters and bryostatins (Igomenova, T. I., 2015, Biochemistry). Upon ligand binding, the C1 domain facilitates the translocation of the PKC enzyme from the cytosol to the plasma membrane, a critical step in the activation of various intracellular signaling pathways. This recruitment triggers a conformational change that releases the kinase's autoinhibitory pseudosubstrate, allowing for substrate phosphorylation and downstream signaling (Kourani et al., 2022, Frontiers in Drug Discovery). Because PKC signaling regulates vital processes such as cell growth, apoptosis, and synaptic plasticity, the C1 domain is a significant therapeutic target for conditions like cancer and Alzheimer's disease. Drugs targeting this domain, such as bryostatin-1 and ingenol mebutate, work by modulating PKC activity, though achieving isoform specificity remains a major challenge in drug development.
Ligands bind to the C1 domain to mimic the natural activator diacylglycerol (DAG), inducing membrane translocation and allosteric activation of the kinase by releasing the pseudosubstrate.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein kinase C C1 domain (C1 domain).